Advances in postoperative care of pediatric cardiac patients

Purpose of review The past two decades have seen tremendous technological advances in the care of infants and children with congenital and acquired heart disease. Recent advances in postoperative management have made it possible to support smaller and more fragile infants, extended the capabilities of extracorporeal circulation, and have brought new and innovative monitoring capabilities to the intensive care unit. Recent findings We chose to focus our review on four main themes: management of pulmonary hypertension, mechanical support of the myocardium, near infrared spectroscopy, and heparin-induced thrombocytopenia. Summary As operative and cardiopulmonary bypass techniques have evolved, early complete repair in neonates and repair of more complex lesions is now possible, creating new challenges for postoperative care in the intensive care unit. Additionally, recognition and management of newly appreciated complications is essential.

[1]  F. Cetta,et al.  Argatroban use during pediatric interventional cardiac catheterization , 2004, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[2]  R. Butler,et al.  Routine mechanical ventricular assist following the Norwood procedure--improved neurologic outcome and excellent hospital survival. , 2004, The Annals of thoracic surgery.

[3]  S. Bratton,et al.  Outcome of pediatric patients treated with extracorporeal life support after cardiac surgery. , 2003, The Annals of thoracic surgery.

[4]  O. Hallioglu,et al.  Comparison of acute hemodynamic effects of aerosolized and intravenous iloprost in secondary pulmonary hypertension in children with congenital heart disease. , 2003, The American journal of cardiology.

[5]  D. Ivy,et al.  Acute hemodynamic effects and home therapy using a novel pulsed nasal nitric oxide delivery system in children and young adults with pulmonary hypertension. , 2003, The American journal of cardiology.

[6]  D. Webb,et al.  Acute endothelin A receptor antagonism improves pulmonary and systemic haemodynamics in patients with pulmonary arterial hypertension that is primary or autoimmune and related to congenital heart disease , 2003, Heart.

[7]  G. Butrous,et al.  Intravenous Sildenafil Is a Potent Pulmonary Vasodilator in Children With Congenital Heart Disease , 2003, Circulation.

[8]  F. Pigula,et al.  Long-term survival after pediatric cardiac transplantation and postoperative ECMO support. , 2003, The Annals of thoracic surgery.

[9]  G. Hempelmann,et al.  Use of inhaled iloprost in a case of pulmonary hypertension during pediatric congenital heart surgery. , 2003, Anesthesiology.

[10]  H. Schäfers,et al.  Intraoperative inhalation of the long-acting prostacyclin analog iloprost for pulmonary hypertension. , 2003, The Journal of thoracic and cardiovascular surgery.

[11]  A. Greinacher,et al.  Heparin-induced thrombocytopenia and cardiac surgery. , 2003, The Annals of thoracic surgery.

[12]  J. Drummond-Webb,et al.  Pediatric arteriovenous extracorporeal membrane oxygenation (ECMO) as a bridge to cardiac transplantation. , 2003, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[13]  Robert L. Kormos,et al.  Mechanical Circulatory Support device database of the International Society for Heart and Lung Transplantation: first annual report--2003. , 2003, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[14]  R. Hetzer,et al.  Pulsatile mechanical cardiac assistance in pediatric patients with the Berlin heart ventricular assist device. , 2003, The journal of extra-corporeal technology.

[15]  C. Leonard,et al.  Neurodevelopmental outcome of infants supported with extracorporeal membrane oxygenation after cardiac surgery. , 2003, Pediatrics.

[16]  P. Monagle,et al.  Heparin‐induced thrombocytopenia in children , 2003, Journal of paediatrics and child health.

[17]  F. Cetta,et al.  Heparin-induced thrombocytopenia with associated thrombosis in children after the Fontan operation: report of two cases. , 2003, Texas Heart Institute Journal.

[18]  R. Kliegman.  The relationship of neonatal feeding practices and the pathogenesis and prevention of necrotizing enterocolitis. , 2003, Pediatrics.

[19]  S. Rich,et al.  Efficacy and Safety of Treprostinil: An Epoprostenol Analog for Primary Pulmonary Hypertension , 2003, Journal of cardiovascular pharmacology.

[20]  R. Ohye,et al.  Use of extracorporeal life support as a bridge to pediatric cardiac transplantation. , 2003, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[21]  B. Christman,et al.  Effect of cardiopulmonary bypass on urea cycle intermediates and nitric oxide levels after congenital heart surgery. , 2003, The Journal of pediatrics.

[22]  T. Severin,et al.  Anticoagulation with Recombinant Hirudin and Danaparoid Sodium in Pediatric Patients , 2002, Seminars in thrombosis and hemostasis.

[23]  A. Redington,et al.  The endothelin antagonist BQ123 reduces pulmonary vascular resistance after surgical intervention for congenital heart disease. , 2002, The Journal of thoracic and cardiovascular surgery.

[24]  H. Laks,et al.  Use of assist devices and ECMO to bridge pediatric patients with cardiomyopathy to transplantation. , 2002, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[25]  Orris,et al.  INHALED ILOPROST FOR SEVERE PULMONARY HYPERTENSION , 2002 .

[26]  T. Severin,et al.  Heparin-Induced Thrombocytopenia in Pediatrics , 2001, Seminars in thrombosis and hemostasis.

[27]  A. Atz,et al.  Sildenafil ameliorates effects of inhaled nitric oxide withdrawal. , 1999, Anesthesiology.

[28]  H. Edmonds,et al.  Benefit of neurophysiologic monitoring for pediatric cardiac surgery. , 1997, The Journal of thoracic and cardiovascular surgery.

[29]  M. Shumate.  Heparin-induced thrombocytopenia. , 1995, The New England journal of medicine.